AtriCure (ATRC) Cost of Revenue (2010 - 2026)

AtriCure (ATRC) has 17 years of Cost of Revenue data on file, last reported at $31.9 million in Q1 2026.

• Quarterly Cost of Revenue rose 3.05% year-over-year to $31.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $134.7 million (up 11.14% YoY) and the FY2025 annual result came in at $133.7 million, up 13.56% from the prior year.
• Cost of Revenue eased to $31.9 million in Q1 2026 per ATRC's latest filing, from $35.2 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $35.2 million in Q4 2025 and bottomed at $19.0 million in Q1 2022.
• The 5-year median for Cost of Revenue is $27.6 million (2024), against an average of $27.5 million.
• The widest annual swing landed in 2022, when Cost of Revenue climbed 28.82%; it then rose 3.05% in 2026.
• Tracing ATRC's Cost of Revenue over 5 years: stood at $22.9 million in 2022, then climbed by 16.64% to $26.7 million in 2023, then grew by 18.45% to $31.7 million in 2024, then grew by 11.07% to $35.2 million in 2025, then fell by 9.17% to $31.9 million in 2026.
• Per Business Quant, the three latest ATRC Cost of Revenue figures stand at $31.9 million (Q1 2026), $35.2 million (Q4 2025), and $32.9 million (Q3 2025).

Peer Comparison